Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori Academic Article uri icon

Overview

MeSH Major

  • Lung Diseases, Interstitial
  • Pulmonary Fibrosis

abstract

  • AZ is effective in preventing COPD exacerbations in patients with HP seropositivity, possibly by modulating TNF pathways related to HP infection.

publication date

  • May 30, 2017

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5450077

Digital Object Identifier (DOI)

  • 10.1186/s12931-017-0594-x

PubMed ID

  • 28558695

Additional Document Info

start page

  • 109

volume

  • 18

number

  • 1